Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ReposiTrak, Inc. (NYSE: TRAK), a Nevada corporation that operates a cloud-based food traceability, compliance and supply chain data platform. Through these filings, investors can review how the company reports its financial results, corporate actions and governance matters in accordance with SEC requirements.
ReposiTrak’s recent Form 8-K filings include disclosures about quarterly cash dividend declarations on its common stock, authorization of a 10b5-1 share repurchase program under a broader repurchase authorization, earnings releases for fiscal quarters and years, and the results of its annual meeting of stockholders. These current reports also reference attached press releases and earnings call transcripts that provide additional detail on financial performance, capital allocation and operational commentary.
In addition to current reports, ReposiTrak files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain audited or reviewed financial statements, management’s discussion and analysis, risk factor disclosures and information on its business, including its focus on food traceability, regulatory compliance and supply chain solutions delivered through cloud-based applications.
Stock Titan’s filings page is designed to surface these documents as they are made available on EDGAR and to pair them with AI-powered summaries that explain the key points in accessible language. Users can quickly identify items such as dividend announcements, share repurchase authorizations, earnings results and shareholder meeting outcomes, and then drill into the underlying SEC reports for more detail. This same interface can also be used to monitor insider and executive transactions reported on forms such as Form 4, as those become available for ReposiTrak insiders.
ReposiTrak, Inc. insider activity shows several transactions by entities associated with Chief Executive Officer Randall K. Fields, who is also a director and 10% owner. RK Fields Charitable 2022, LLC sold 5,000 shares of common stock on January 5, 2026 at a weighted average price of $12.2686 per share and 2,500 shares on January 6, 2026 at a weighted average price of $11.7238 per share under a pre-arranged Rule 10b5-1 trading plan set up to help meet charitable commitments. After these sales, this LLC held 155,000 and then 152,500 common shares. On December 31, 2025, Riverview Financial Corp and the reporting person’s spouse disposed of 60,411 and 1,402 shares of Series B preferred stock at $10.70 per share, leaving 169,797 and 3,704 preferred shares, respectively. As of that date, Fields also held 3,483,955 common shares directly, plus additional indirect common holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. insider Randall K. Fields, who serves as Chief Executive Officer, director, and a 10% owner, reported an automatic sale of company stock. On 12/31/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 7,500 shares of common stock at a weighted average price of $12.3449 per share under a pre-established Rule 10b5-1 trading plan. The filing states that this trading plan was set up to help Mr. Fields meet certain charitable commitments. After the reported transaction, Mr. Fields continues to report substantial holdings in ReposiTrak common and preferred stock through multiple entities and family holdings.
ReposiTrak, Inc. director reports stock grant and sales
A director of ReposiTrak, Inc. (TRAK) reported several transactions in the company’s common stock. On November 5, 2025, he acquired 1,265 shares, issued in lieu of cash compensation for his board service for the quarter ended September 30, 2025. On December 22, 2025, he sold 1,641 shares at a weighted average price of $13.1981, and on December 23, 2025 he sold an additional 18,906 shares at a weighted average price of $13.164. After these transactions, he beneficially owned 561,869 shares of ReposiTrak common stock, held directly.
ReposiTrak, Inc. director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025. These shares were issued instead of cash payments for his service on the company’s Board of Directors for the quarter ended September 30, 2025.
After this transaction, he beneficially owned 199,147 shares of common stock directly, 587,476 shares indirectly through a trust, 2,775 shares indirectly through his spouse, and 39,704 shares of Series B preferred stock directly.
ReposiTrak, Inc. chief executive officer, director and 10% owner Randall K. Fields reported small insider stock sales executed under a Rule 10b5-1 trading plan. On 12/22/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 3,000 shares of common stock at a weighted average price of $13.3687 per share. On 12/23/2025, the same entity sold an additional 4,500 shares at a weighted average price of $13.2618 per share. The filing explains that the trading plan was adopted by Fields, in his capacity as trustee of a charitable remainder unitrust, to help meet his charitable commitments. After these sales, Fields continues to beneficially own 3,483,955 shares of common stock directly, plus additional indirect holdings through family and affiliated entities.
TraK (TRAK) insider plans to sell common stock under Rule 144. A notice was filed for the proposed sale of 18,906 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $248,878.58, on or about 12/23/2025 on the NYSE. The issuer has 18,288,455 shares of this class outstanding. The shares to be sold were acquired between 2013 and 2015, mostly as restricted stock vesting under a registered plan in exchange for services, plus an open market purchase for cash. Over the past three months, the same seller disposed of 1,641 common shares for gross proceeds of $21,658.08. The seller represents that he is not aware of undisclosed material adverse information about the issuer.
A shareholder of TRAK has filed a notice of proposed sale of common stock under Rule 144. The filing covers 1,641 common shares, with an aggregate market value of $21,658.08, to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/22/2025. The shares are part of a total of 18,288,455 shares of this class outstanding. The seller originally acquired these shares on 09/19/2013 in an open market purchase from the issuer, paid in cash.
ReposiTrak, Inc. disclosed that its board has declared a quarterly cash dividend of $0.02 per share, which equates to $0.08 per share on an annual basis, on its common stock. The dividend is scheduled to be paid on or about February 13, 2026 to stockholders who are on record as of December 31, 2025. The company furnished this information through a press release attached as an exhibit, emphasizing that it is being provided for informational purposes and is not treated as filed for liability purposes under securities laws.
ReposiTrak, Inc. reported that CEO, director and 10% owner Randall K. Fields sold 7,500 shares of common stock on 12/16/2025 at a weighted average price of $13.2977, coded as an "S" sale transaction.
The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, and was established to help meet some of his charitable commitments.
After this transaction, Fields beneficially owned 3,483,955 shares of common stock directly, 175,000 shares of common stock indirectly through RK Fields Charitable 2022, LLC, 615,260 common and 229,262 Series B preferred shares through Riverview Financial Corp, 30,667 common and 5,320 Series B preferred shares through his spouse, and 333,643 common shares through Fields Management, Inc.
ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.
The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.
Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.